ÖÜ¿¯ 1997Äê1Ô´´¿¯£¨×ܵÚ315ÆÚ£© µÚ12¾í µÚ7ÆÚ 2008Äê2ÔÂ12ÈÕ³ö°æ


5-·úÄòà×शÔÌåÍâÅàÑøñ£ºÛ¸í´ñ³ÉÏËάϸ°ûµÄÒÖÖÆ¼°°ëÊýÒÖ֯ō¶È*¡ï

×ó×Ú±¦£¬ÀîС¾²£¬Äþ½ðÁú£¬¹¨éóÒ»£¬ÅË×£±ó£¬ÖÜ è¤


¿ÎÌâ±³¾°£º¿ÎÌâΪ°²»ÕÊ¡½ÌÓýÌü×ÔÈ»¿ÆÑ§»ù½ð×ÊÖúÏîÄ¿(070413102)¡£5-·úÄòà×à¤ÊÇ´«Í³¿¹´úлҩÎÆäÓÕµ¼¶àÖÖÖ×Áöϸ°ûµÄµòÍöÒѵõ½³ä·ÖÂÛÖ¤£¬½üÀ´¹úÄÚÍâ¾ùÓÐ5-·úÄòà×à¤Ó¦ÓÃÓÚ²¡ÀíÐÔñ£ºÛÖÎÁƵÄÁÙ´²±¨µÀ£¬µ«ÆäÒ©Îï×÷ÓûúÖÆÉÐÎÞÈ·ÇÐÈ϶¨¡£±¾ÊµÑéÀûÓÃÌåÍâϸ°ûÅàÑø¼¼Êõ£¬Ì½Ë÷5-·úÄòà×शÔñ£ºÛ¸í´ñ³ÉÏËάϸ°ûÔöÖ³ºÍµòÍöµÄÉúÎïѧӰÏì¡£

Ó¦ÓÃÒªµã£ºÊµÑé֤ʵµÍŨ¶È5-·úÄòà×शÔÌåÍâÅàÑøñ£ºÛ¸í´ñ³ÉÏËάϸ°ûÓÐÒÖÖÆÔöÖ³ºÍÓÕµ¼µòÍö×÷Óá£ÔÚÒ©Îïϸ°û¶¾ÐÔ½ÏÈõµÄŨ¶È·¶Î§Ï£¬ËæÒ©ÎïŨ¶ÈµÄÔö¼Ó£¬Ï¸°ûµòÍöÂÊËæÖ®Éý¸ß¡£²ÉÓõÍŨ¶È¡¢¶ÌÖÜÆÚ×¢Éä5-·úÄòà×िÉÄÜÊÇÖÎÁÆñ£ºÛ¸í´ñ½ÏΪ°²È«¡¢ÓÐЧµÄ·½·¨¡£

ͬÐÐÆÀ¼Û£ºÎÄÕ¹۲ì5-·úÄòà×शÔÌåÍâñ£ºÛ¸í´ñ³ÉÏËάϸ°ûµÄÉúÎïѧӰÏìÊǶÔ5-·úÄòà×à¤ÖÎÁÆñ£ºÛ¸í´ñ»úÖÆµÄÓÐÒæÌ½ÌÖ£¬ÌرðÊÇ̽ÌÖÁË5-·úÄòà×शÔñ£ºÛ¸í´ñ³ÉÏËάϸ°ûµÄ°ëÊýÒÖ֯ō¶È£¬¶ÔÓÚÖ¸µ¼ÁÙ´²Ó¦ÓþßÓÐÖØÒª¼ÛÖµ¡£ÿ

ÕªÒª
Ä¿µÄ£º¹úÄÚÍâһЩѧÕßʹÓô«Í³¿¹´úлҩÎï5-·úÄòà×षÀÖ¹ÏËά»¯£¬ÔÚÖÎÁÆñ£ºÛ¸í´ñ·½ÃæÈ¡µÃÁËÒ»¶¨µÄÁÙ´²ÁÆÐ§£¬µ«¶ÔÆäÒ©Îï×÷ÓûúÖÆÒÔ¼°ÁÙ´²Ò©ÎïÓ¦ÓõÄŨ¶ÈÉÐÎÞÈ·ÇÐÈ϶¨¡£ÊµÑéÄâ½øÒ»²½ÑéÖ¤5-·úÄòà×शÔÌåÍâÅàÑøñ£ºÛ¸í´ñ³ÉÏËάϸ°ûÔöÖ³µÄÒÖÖÆÒÔ¼°°ëÊýÒÖ֯ō¶È¡£
·½·¨£ºÊµÑéÓÚ2006-09/2007-07ÔÚ°²»ÕÒ½¿Æ´óѧ΢ÉúÎï½ÌÑÐÊÒ¼°°²»ÕÒ½¿Æ´óѧ¸½ÊôÒ½ÔºÖÐÐÄʵÑéÊÒÍê³É¡£¢ÙʵÑé²ÄÁÏ£º6Àýñ£ºÛ¸í´ñ£¨¶ú´¹¡¢´óÍȸ÷1Àý¡¢ÐØÇ°¡¢Éϱ۸÷2Àý£©¾ùΪ°²»ÕÒ½¿Æ´óѧ¸½ÊôÒ½ÔºÕûÐÎÍâ¿ÆÊÖÊõ²¡Àý£¬¾ùÎÞϵͳÐÔ¼²²¡ºÍ¼¤ËØ¡¢ÆäËûÒ©Îï×¢ÉäÊ·£¬¶ÔÓÃÓÚʵÑéµÄËùÈ¡×éÖ¯»¼Õß¾ùÖªÇéͬÒâ¡£ÖÎÁÆ·½°¸¾­Ò½ÔºÒ½Ñ§Â×ÀíίԱ»áÅú×¼¡£¢ÚʵÑé·½·¨£º³ÉÏËάϸ°ûÌåÍâÔ­´úÅàÑø£¬´ýϸ°ûÈںϺ󴫴ú£¬ÊµÑéËùÓÃϸ°û¾ùΪ´¦ÓÚ4~8´ú¶ÔÊýÉú³¤ÆÚµÄ³ÉÏËάϸ°û¡£½«²»Í¬Å¨¶È5-·úÄòà×à¤(0.1£¬0.2£¬0.4£¬0.8£¬1.6 g/L)·Ö±ð¶Ô4~8´úñ£ºÛ¸í´ñ³ÉÏËάϸ°û½øÐиÉÔ¤72 h¡£ÔÙÑ¡ÓýӽüIC50µÄ5¸öŨ¶È£º0.2£¬0.3£¬0.4£¬0.5£¬0.6 g/L£¬×÷ΪÓàÏÂʵÑéŨ¶È¡£¢ÛʵÑéÆÀ¹À£º²ÉÓÃËļ׻ùżµªßòÑαÈÉ«·¨¼ì²â¸÷Ũ¶ÈÒ©Îï¶Ô³ÉÏËάϸ°ûµÄÒÖÖÆÂÊ£¬¼ÆËã5-·úÄòà×शÔñ£ºÛ¸í´ñ³ÉÏËάϸ°ûµÄ°ëÊýÒÖ֯ō¶È£¨IC50£©Öµ¡£Ó¦ÓÃÁ÷ʽϸ°ûÊõ·ÖÎö·¨¹Û²ì5-·úÄòà×सÉÔ¤ºóñ£ºÛ¸í´ñ³ÉÏËάϸ°ûµÄϸ°ûÖÜÆÚ±ä»¯¼°Ï¸°ûµòÍö°Ù·ÖÂÊ£»Ó¦ÓÃHoechst 33258Ó«¹âȾɫ·¨¹Û²ìµòÍö³ÉÏËάϸ°ûµÄÐÎÌ¬Ñ§ÌØÕ÷¡£
½á¹û£º6Àýñ£ºÛ¸í´ñ±ê±¾Ô­´úÅàÑø³ÉÏËάϸ°û³É»îÁ¼ºÃ£¬¾ùÓÃÓÚʵÑ飬½øÈë½á¹û·ÖÎö¡£¢Ù0.1£¬0.2£¬0.4£¬0.8£¬1.6 g/L 5-·úÄòà×सÉÔ¤72 h ºó£¬Ï¸°ûÒÖÖÆÂÊ×é¼äÁ½Á½±È½Ï²îÒì¾ùÓÐÏÔÖøÐÔ£¨P < 0.01£©¡£×÷ͼµÃ°ëÊýÒÖ֯ō¶ÈIC50Ϊ£¨0.400¡À0.032£©g/L¡£¢Ú0.2£¬0.3£¬0.4£¬0.5£¬0.6 g/L 5-·úÄòà×सÉÔ¤48 h ºó£¬Ï¸°ûµòÍöÂÊ×é¼äÁ½Á½±È½Ï²îÒìÏÔÖø£¨P < 0.05£©£¬Óë¶ÔÕÕ×é±È½Ï£¬²îÒìÓÐÏÔÖøÐÔÒâÒå(P < 0.01)£»ÊµÑé×éÓë¶ÔÕÕ×éϸ°ûÖÜÆÚ°Ù·ÖÊý±È½Ï£¬±íÏÖΪG0/G1ÆÚÍ£ÖÍ£¬SÆÚ¼õÉÙ£¬¸÷×é¼äÁ½Á½±È½Ï²îÒìÓÐÏÔÖøÐÔÒâÒ壨P < 0.05£©¡£¢Û¸÷Ũ¶È5-·úÄòà×सÉÔ¤48 h ºó£¬Hoechst 33258Ó«¹âȾɫ¹Û²ì³ÉÏËάϸ°û¾ù·¢Éú²»Í¬³Ì¶ÈµòÍö¡£
½áÂÛ£º5-·úÄòà×शÔñ£ºÛ¸í´ñ³ÉÏËάϸ°û¾ßÓÐÒÖÖÆÔöÖ³ºÍÓÕµ¼µòÍöµÄ×÷ÓᣵÍŨ¶È¡¢¶ÌÖÜÆÚ×¢Éä5-·úÄòà×िÉÄÜÊÇÖÎÁÆñ£ºÛ¸í´ñµÄÒ»ÖÖÐÂ˼·¡£
¹Ø¼ü´Ê£ºñ£ºÛ¸í´ñ£»·úÄòà×ण»³ÉÏËάϸ°û£»Ï¸°ûÔöÖ³£»Ï¸°ûµòÍö£»×éÖ¯¹¹½¨

×ó×Ú±¦£¬ÀîС¾²£¬Äþ½ðÁú£¬¹¨éóÒ»£¬ÅË×£±ó£¬ÖÜ褣®5-·úÄòà×शÔÌåÍâÅàÑøñ£ºÛ¸í´ñ³ÉÏËάϸ°ûµÄÒÖÖÆ¼°°ëÊýÒÖ֯ō¶È[J].Öйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´£¬2008£¬12(7):1235-1238 [www.zglckf.com/zglckf/ejournal/upfiles/08-7/7k-1235(ps).pdf]



°²»ÕÒ½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÕûÐÎÍâ¿Æ£¬°²»ÕÊ¡ºÏ·ÊÊÐ 230032

×ó×Ú±¦¡ï£¬ÄУ¬1981ÄêÉú£¬°²»ÕÊ¡°²ÇìÊÐÈË£¬ºº×壬°²»ÕÒ½¿Æ´óѧÔÚ¶Á˶ʿ£¬×¡ÔºÒ½Ê¦£¬Ö÷Òª´ÓÊÂñ£ºÛ»ù´¡·½ÃæµÄÑо¿¡£
ayzuozongbao@
yahoo.com.cn

ͨѶ×÷ÕߣºÀîС¾²£¬½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦£¬°²»ÕÒ½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÕûÐÎÍâ¿Æ£¬°²»ÕÊ¡ºÏ·ÊÊÐ 230032
lixiaojing5@163.com

°²»ÕÊ¡½ÌÓýÌü×ÔÈ»¿ÆÑ§»ù½ð×ÊÖúÏîÄ¿(0704131 02)*

ÖÐͼ·ÖÀàºÅ:R318
ÎÄÏ×±êʶÂë:A
ÎÄÕ±àºÅ:1673-8225
(2008)07-01235-04

ÊÕ¸åÈÕÆÚ£º2007-11-01
ÐÞ»ØÈÕÆÚ£º2007-12-28
(07-50-11-5964/WL¡¤A£©


Inhibitory effect of 5-fluorouracil on in vitro cultured human keloid fibroblasts and determination of 50% inhibitory concentration of 5-fluorouracil

Abstract

AIM£º
5- fluorouracil is always used to prevent fibrosis, which has achieved certain curative effect on keloid in clinic. However, its mechanism and application dosage in clinic are still uncertain. This study explored the inhibitory effects and concentration of 5-fluorouracil on the proliferation of human keloid fibroblasts in vitro.
METHODS: The experiment was performed at Microbes Department of Anhui Medical University and the center laboratory of Affiliated Hospital of Anhui Medical University from September 2006 to July 2007. ¢ÙKeloids of ear lobe, thigh, chest and upper arm were derived from 6 cases of Department of Plastic Surgery, First Affiliated Hospital of Anhui Medical University. All the patients did not have any systemic disease or drug injection like hormone. The informed consent was obtained from the patients, and the experiment was admitted by the Hospital Ethics Committee. ¢ÚFibroblasts were cultured in vitro, and the ¢ô-¢ø generation cells at exponential phase of growth were used for experiment. Keloid fibroblasts were stimulated with 5-fluorouracil (0.1, 0.2, 0.4, 0.8, and 1.6 g/L) for 72 hours. In addition, 0.2, 0.3, 0.4, 0.5 and 0.6 g/L 5-fluorouracil were prepared for the following experiment. ¢ÛThe inhibition ratio and 50% inhibitory concentration (IC50) were calculated by MTT. The cell apoptosis and cell cycle were measured by flow cytometry. The cell morphological character was observed by Hoechst 33258 fluorescent staining.
RESULTS: Six keloid specimens were primarily cultured well, and all were included in the final analysis. ¢ÙAfter 5-fluorouracil (0.1, 0.2, 0.4, 0.8, and 1.6 g/L) intervention for 72 hours, the inhibition ratio were significantly different between every two groups (P < 0.01). The IC50 was (0.400¡À0.032) g/L by mapping. ¢ÚAfter 5-fluorouracil (0.2, 0.3, 0.4, 0.5, and 0.6 g/L) intervention for 48 hours, the apoptosis rate had significant differences between every two groups (P < 0.05). Compared with the control group cells, the differences were statistically significant (P < 0.01). Compared with the control group cells, the number of experiment cells at phase G0/G1 significantly increased and S decreased (P < 0.05). ¢ÛBy Hoechst 33258 fluorescent staining, the keloid fibroblasts interfered with 5-fluorouracil showed apoptosis at different extents.
CONCLUSION: 5-fluorouracil can inhibit proliferation and induce apoptosis of human keloid fibroblasts in vitro. Low concentration and short-period injection with 5-fluorouracil would be a new ideal for keloid treatment.

Zuo ZB, Li XJ, Ning JL, Gong YY, Pan ZB, Zhou Y. Inhibitory effect of 5-fluorouracil on in vitro cultured human keloid fibroblasts and determination of 50% inhibitory concentration of 5-fluorouracil .Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu 2008;12(7):1235-1238(China) [www.zglckf.com/zglckf/ejournal/upfiles/08-7/7k-1235(ps).pdf]


Department of Plastic Surgery, First Affiliated Hospital of Anhui Medical University, Hefei 230032, Anhui Province, China

Zuo Zong-bao¡ï, Studying for master's degree, Resident physician Department of Plastic Surgery, First Affiliated Hospital of Anhui Medical University, Hefei 230032, Anhui Province, China
ayzuozongbao@
yahoo.com.cn

Correspondence to: Li Xiao-jing, Professor, Tutor of master, Department of Plastic Surgery, First Affiliated Hospital of Anhui Medical University, Hefei 230032, Anhui Province, China
lixiaojing5@163.
com

Supported by: the Natural Science Foundation of Anhui Province Education Department, No. 070413102*

Received: 2007-11-01 Accepted: 2007-12-28

Advertisement

¡¶Öйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´¡·ÔÓÖ¾Éç
µØÖ·£ºÉòÑô1200ÓÊÕþÐÅÏä Óʱࣺ110004 ´«Õ棺+86 24 23394178